Core Stability, Functional Capacity, Balance, Strength, and Fatigue in Pediatric Demyelinating Diseases
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6-18
SponsorIstanbul University - Cerrahpasa
About this trial
This study aims to evaluate balance ability, core stability, functional capacity, lower extremity muscle strength, and fatigue levels in children diagnosed with central nervous system demyelinating diseases, in order to contribute to the development of evidence-based and individualized rehabilitation strategies.
Eligibility criteria
Qualifiers
Age between 6 and 18 years
Diagnosed with a pediatric demyelinating disease
No relapse within the last 3 months
No botulinum toxin (Botox) injections within the last 3 months
Disqualifiers
History of concomitant autoimmune diseases
Refusal of the patient and/or caregiver to participate in the study
History of another primary neurological disease
Cognitive impairment that limits understanding of instructions and participation in assessments
Trial design
Treatments tested in this trial
- No ADT
Treatment groups
32 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov